NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes
Authors
Keywords
-
Journal
Diabetology & Metabolic Syndrome
Volume 14, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-05-03
DOI
10.1186/s13098-022-00837-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of DPP-4 inhibitors on plasma levels of BNP and NT-pro-BNP in type 2 diabetes mellitus
- (2022) Liying Mu et al. Diabetology & Metabolic Syndrome
- Performance of the recommended ESC/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus
- (2021) Suriya Prausmüller et al. Cardiovascular Diabetology
- Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: a prospective cohort study
- (2021) Hui-Hui Liu et al. Cardiovascular Diabetology
- NT-proBNP versus routine clinical risk factors as a predictor of cardiovascular events or death in people with dysglycemia – A brief report from the ORIGIN trial
- (2021) Magnus O. Wijkman et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial
- (2021) James L. Januzzi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Molecular Signaling Mechanisms and Function of Natriuretic Peptide Receptor-A in the Pathophysiology of Cardiovascular Homeostasis
- (2021) Kailash N. Pandey Frontiers in Physiology
- Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality
- (2021) Frederik H. Verbrugge et al. EUROPEAN HEART JOURNAL
- Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes
- (2020) Mark C. Petrie et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of canagliflozin in patients with type 2 diabetes and chronic heart failure: a randomized trial (CANDLE)
- (2020) Atsushi Tanaka et al. ESC Heart Failure
- The impact of the glucagon‐like peptide‐1 receptor agonist liraglutide on natriuretic peptides in heart failure patients with reduced ejection fraction with and without type 2 diabetes
- (2020) Roni Nielsen et al. DIABETES OBESITY & METABOLISM
- Opposing Associations of NT-proBNP With Risks of Diabetes and Diabetes-Related Complications
- (2020) Anna Birukov et al. DIABETES CARE
- NT‐proBNP by Itself Predicts Death and Cardiovascular Events in High‐Risk Patients With Type 2 Diabetes Mellitus
- (2020) Marcus V. B. Malachias et al. Journal of the American Heart Association
- NT-proBNP: Can We Better Utilize Biomarkers in Patients With Diabetes?
- (2020) Matthew A. Cavender et al. DIABETES CARE
- C-type natriuretic peptide co-ordinates cardiac structure and function
- (2019) Amie J Moyes et al. EUROPEAN HEART JOURNAL
- Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis
- (2019) Yechen Han et al. Cardiovascular Diabetology
- Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial
- (2019) Michael E. Nassif et al. CIRCULATION
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
- (2019) Francesco Cosentino et al. EUROPEAN HEART JOURNAL
- NT-proBNP predicts the cardio-renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk
- (2018) Nienke M.A. Idzerda et al. DIABETES OBESITY & METABOLISM
- Atrial and brain natriuretic peptides: Hormones secreted from the heart
- (2018) Yasuaki Nakagawa et al. PEPTIDES
- Impact of dapagliflozin on left ventricular diastolic function of patients with type 2 diabetic mellitus with chronic heart failure
- (2018) Fumitaka Soga et al. Cardiovascular Diabetology
- Snake Venom Peptides: Tools of Biodiscovery
- (2018) Aisha Munawar et al. Toxins
- Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes
- (2017) James L. Januzzi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Serotonin improves glucose metabolism by Serotonylation of the small GTPase Rab4 in L6 skeletal muscle cells
- (2017) Ramona Al-Zoairy et al. Diabetology & Metabolic Syndrome
- Role of B‐Type Natriuretic Peptide and N‐Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus
- (2017) Emil Wolsk et al. Journal of the American Heart Association
- Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study
- (2016) Mauro Gori et al. DIABETES CARE
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. EUROPEAN HEART JOURNAL
- Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis
- (2016) Peter Willeit et al. Lancet Diabetes & Endocrinology
- Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes
- (2015) Bernt Johan von Scholten et al. Cardiovascular Diabetology
- Identifying Novel Biomarkers for Cardiovascular Events or Death in People With DysglycemiaClinical Perspective
- (2015) Hertzel C. Gerstein et al. CIRCULATION
- Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes
- (2015) Helen C. Looker et al. DIABETOLOGIA
- Natriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events
- (2015) Risto Kerkelä et al. Journal of the American Heart Association
- Racial Differences in Circulating Natriuretic Peptide Levels: The Atherosclerosis Risk in Communities Study
- (2015) D. K. Gupta et al. Journal of the American Heart Association
- Changes in liraglutide-induced body composition are related to modifications in plasma cardiac natriuretic peptides levels in obese type 2 diabetic patients
- (2014) Chun-Jun Li et al. Cardiovascular Diabetology
- Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial
- (2014) Benjamin M. Scirica et al. CIRCULATION
- Metformin treatment may be associated with decreased levels of NT-proBNP in patients with type 2 diabetes
- (2013) M Rosiak et al. Advances in Medical Sciences
- NH 2 -Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes
- (2013) Mariana Lazo et al. DIABETES
- N-Terminal Probrain Natriuretic Peptide Is a Stronger Predictor of Cardiovascular Mortality Than C-Reactive Protein and Albumin Excretion Rate in Elderly Patients With Type 2 Diabetes
- (2013) Graziella Bruno et al. DIABETES CARE
- The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes
- (2013) Graham S. Hillis et al. DIABETES CARE
- PONTIAC (NT-proBNP Selected PreventiOn of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease)
- (2013) Martin Huelsmann et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- NT Pro BNP Plasma Level and Atrial Volume Are Linked to the Severity of Liver Cirrhosis
- (2013) Anna Licata et al. PLoS One
- Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)
- (2011) John J.V. McMurray et al. AMERICAN HEART JOURNAL
- Association Between Cardiac Biomarkers and the Development of ESRD in Patients With Type 2 Diabetes Mellitus, Anemia, and CKD
- (2011) Akshay S. Desai et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial
- (2011) Martin Andreas et al. Cardiovascular Diabetology
- The paradox of low BNP levels in obesity
- (2011) Aldo Clerico et al. HEART FAILURE REVIEWS
- Low Plasma Level of Atrial Natriuretic Peptide Predicts Development of Diabetes: The Prospective Malmö Diet and Cancer Study
- (2011) Martin Magnusson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study
- (2010) A. P. Kengne et al. DIABETOLOGIA
- NT-pro-BNP is associated with inducible myocardial ischemia in mildly symptomatic type 2 diabetic patients
- (2009) Jacobijne J. Wiersma et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Natriuretic peptides: linking heart and adipose tissue in obesity and related conditions - a systematic review
- (2009) A. M. R. Beleigoli et al. Obesity Reviews
- Níveis séricos de NT pro-BNP: relação com função sistólica e diastólica nas miocardiopatias e pericardiopatias
- (2008) Charles Mady et al. Arquivos Brasileiros de Cardiologia
- Determinants of plasma NT-pro-BNP levels in patients with atrial fibrillation and preserved left ventricular ejection fraction
- (2008) Konstantinos P. Letsas et al. Clinical Research in Cardiology
- NT-proBNP has a high negative predictive value to rule-out short-term cardiovascular events in patients with diabetes mellitus
- (2008) M. Huelsmann et al. EUROPEAN HEART JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search